Evidence map›Paper›PMID 42607037›Full record

ArticlePLOS global public health2026

Understanding barriers to effective malaria diagnosis and treatment: A mixed-methods study in Uganda, Nigeria, and Ivory Coast.

Nekoye Otsyula, Nareen Krishna Polavarapu, Annie Syntosi, Will Bench, Gursimran Kaur, Anna Meadows, Rebecca L West, Matthew Dewhurst, Pushpendra Kumar Mishra, Irene Olisamedua Obi and 4 more

Abstract read
In one paragraph

Article in PLOS global public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Nekoye OtsyulaNovartis Pharma Services Limited, Nairobi, Kenya.ORCID https://orcid.org/0000-0002-0912-8575
Nareen Krishna PolavarapuNovartis Health Care Private Limited, Chennai, India.ORCID https://orcid.org/0000-0003-2938-7256
Annie SyntosiNovartis Pharma AG, Basel, Switzerland.
Will BenchIpsos, London, United Kingdom.
Gursimran KaurIpsos, London, United Kingdom.ORCID https://orcid.org/0000-0001-9306-2638
Anna MeadowsIpsos, London, United Kingdom.
Rebecca L WestIpsos, London, United Kingdom.
Matthew DewhurstIpsos, London, United Kingdom.
Pushpendra Kumar MishraIpsos, Lagos, Nigeria.
Irene Olisamedua ObiIpsos, Lagos, Nigeria.
Olamide Idayat AdigunIpsos, Lagos, Nigeria.ORCID https://orcid.org/0000-0002-1714-5017
Emmanuel Nespaul OdongoIpsos, Kampala, Uganda.
Peninnah NanziriIpsos, Kampala, Uganda.
Caroline BoultonNovartis Pharma AG, Basel, Switzerland.ORCID https://orcid.org/0009-0009-7508-6316

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Malaria remains a global health challenge despite decades of intervention. We conducted a mixed-methods study using the MAPPS behavioural science framework to identify and explore behaviours relating to timely access and better adherence to antimalarials, and to offer initial ideas for interventions. Research was conducted in Uganda, Nigeria, and Ivory Coast following local ethical approval. First, qualitative face-to-face interviews were conducted with n = 18 adults with experience of malaria, n = 36 caregivers of children with experience of malaria, and n = 36 healthcare professionals (HCPs) with experience treating patients with malaria, to identify and explore the behavioural drivers and barriers to access and adherence. Cross-sectional quantitative surveys were then conducted face-to-face with respondents with experience of malaria (n = 311 adults, n = 458 caregivers, n = 532 HCPs) to quantify the incidence of the different drivers and barriers. The sample included representation from rural and urban areas, and public and private healthcare settings. This research identified key behaviours that delayed access and adherence. One-third (33%) of adults and caregivers reported delayed care-seeking from a healthcare facility when experiencing symptoms. Over a third (36%) reported not being offered a diagnostic test to confirm their diagnosis when they last sought care for malaria. 56% reported prematurely discontinuing their antimalarial medication, with 41% stating that treatment can be stopped once symptoms subside. Despite current interventions, behavioural barriers to effective malaria treatment and prevention persist. This research identified and quantified key barriers, including difficulty in identifying symptoms specific to malaria, lack of specified responsibility in testing and difficulties adhering to treatment. Communication with, and education of, patients and caregivers that emphasise the importance of seeking early care are recommended. In addition, interventions encouraging HCPs to offer, and patients or caregivers to request, appropriate testing should be explored. Finally, the use of social norming interventions to promote completion of treatment courses is also recommended.

Identifiers

PMID42607037
PMCPMC13480639

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.